Enzyme replacement therapies are high-value biologic medicines that often move through specialty pharmacy, hospital, home-infusion, and clinical distribution lanes. The packout should protect the refrigerated range, avoid freeze contact, protect fragile vials and cartons, and create a clear temperature record for receiving. Because dose value and patient timing can be high, the route plan must be more controlled than an ordinary chilled parcel.
Enzyme replacement therapy planning data
| Typical target range | Many enzyme replacement therapies require 2-8 C refrigerated handling; always follow the approved label and local SOP. |
|---|---|
| Humidity control | Protect vial cartons, inserts, and labels from condensation because receiving teams may need clean lot and expiry data. |
| Pre-cooling | Use preconditioned shippers, coolant, and separators; avoid loading product during prolonged room-temperature staging. |
| Packaging pressure | Use vial trays or carton support to protect glass, stoppers, labels, and specialty infusion packaging. |
| Coolant position | Use conditioned 2-8 C coolant with a no-freeze buffer. Do not place vials against frozen gel packs. |
| Transport duration | Validate 24-96 h courier or specialty pharmacy lanes with summer and winter profiles where relevant. |
| Common losses | Freeze contact, warm dwell, label wetting, vial breakage, carton crush, missing temperature data, and rejected receiving. |
| Tempk packaging fit | Medical insulated shipper, 2-8 C PCM, vial support insert, dry barrier, absorbent liner, tamper seal, and logger. |
Why enzyme therapies need a stronger cold-chain package
Enzyme products can be sensitive to temperature excursions and rough handling. The product may ship in small vial counts, which are vulnerable to cold spots when coolant mass is too close. At the same time, warm exposure during last-mile dwell can create a release issue. The package must control both ends of the range while protecting labels, vials, stoppers, cartons, and infusion documentation.
Tempk would normally use a qualified insulated shipper, conditioned 2-8 C PCM, a vial support insert, absorbent liner, dry barrier, and a tamper-evident closure. The logger should sit in the payload zone and, for high-risk lanes, an edge logger can help identify cold-wall or warm-corner risk. Route validation should test actual vial count, carton format, seasonal ambient profile, courier timing, and receiving workflow.
Recommended Tempk approach
Confirm the approved label, product specification, route duration, patient-delivery deadline, and receiving criteria before choosing the shipper. At receiving, review temperature record, label readability, carton dryness, glass condition, tamper seal, and route time. eCFR drug warehousing and distribution rules emphasize written procedures, appropriate storage conditions, and lot traceability; the package should make those controls easier to document.
